A cell-free assay to estimate the neutralizing capacity of granulocyte―macrophage colony-stimulating factor autoantibodiesURANO, Shinya; KANEKO, Chinatsu; NEI, Takahito et al.Journal of immunological methods. 2010, Vol 360, Num 1-2, pp 141-148, issn 0022-1759, 8 p.Article

GM-CSF-secreting melanoma vaccinesDRANOFF, Glenn.Oncogene (Basingstoke). 2003, Vol 22, Num 20, pp 3188-3192, issn 0950-9232, 5 p.Article

Régulation de l'expression génique du GM-CSF dans des cellules hématopoïétiques humaines = Regulation of GM-CSF gene expression in human hematoipoietic cellsRazanajaona, Diane; Mannoni, Patrice.1992, 99 p.Thesis

A recombinant human G-CSF/GM-CSF fusion protein from E. coli showing colony stimulating activity on human bone marrow cellsAH YOUNG LEE; HYE KYUNG CHUNG; HYUN JOO YOUN et al.Biotechnology letters. 2003, Vol 25, Num 3, pp 205-211, issn 0141-5492, 7 p.Article

Gene therapy with GM-CSF, interleukin-4 and herpes simplex virus thymidine kinase shows strong antitumor effect on lung cancerPARK, Kyung-Ho; GYESU KIM; SHIM, Young-Soo et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1559-1564, issn 0250-7005, 6 p.Article

Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosisTAZAWA, Ryushi; HAMANO, Emi; ISHIGE, Ikuo et al.American journal of respiratory and critical care medicine. 2005, Vol 171, Num 10, pp 1142-1149, issn 1073-449X, 8 p.Article

Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodiesROLLMAN, E; HINKULA, J; ARTEAGA, J et al.Gene therapy (Basingstoke). 2004, Vol 11, Num 14, pp 1146-1154, issn 0969-7128, 9 p.Article

Effect of GM-CSF on antifungal activity of human phagocytesBRUNMER, Elmer; STEVENS, David A.Immunomodulators as promising therapeutic agents against infectiois diseases 2004. 2004, pp 13-21, isbn 81-7736-174-0, 9 p.Book Chapter

Intérêt thérapeutique et économique du GM-CSF dans le traitement des leucémies aiguës myéloblastiques du sujet âgé : protocole GOELAM Sa3 = Cost-effectiveness analysis of GOELAM Sa3, a randomized placebo-controlled protocol of GM-CSF for elderly patients with AMLWORONOFF-LEMSI, M. C; WITZ, F; ARVEUX, P et al.Thérapie (Paris). 2001, Vol 56, Num 2, pp 131-133, issn 0040-5957, 3 p.Conference Paper

GM-CSF enhances neural differentiation of bone marrow stromal cellsXINGJIAN LIN; YINGDONG ZHANG; JINGDE DONG et al.Neuroreport (Oxford). 2007, Vol 18, Num 11, pp 1113-1117, issn 0959-4965, 5 p.Article

Gene transfer of SHIP-1 inhibits proliferation of juvenile myelomonocytic leukemia cells carrying KRAS2 or PTPN11 mutationsMETZNER, A; HORSTMANN, M. A; FEHSE, B et al.Gene therapy (Basingstoke). 2007, Vol 14, Num 8, pp 699-703, issn 0969-7128, 5 p.Article

Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effectCHOI, K.-J; KIM, J.-H; LEE, Y.-S et al.Gene therapy (Basingstoke). 2006, Vol 13, Num 13, pp 1010-1020, issn 0969-7128, 11 p.Article

Interleukine-15 et contrôle de l'hématopoïèse = Interleukin-15 and hematopoiesisGIRON-MICHEL, Julien; BROUTY-BOYE, Danièle; LE BOUSSE-KERDILES, M.-C et al.Hématologie (Montrouge). 2004, Vol 10, Num 2, pp 135-145, issn 1264-7527, 11 p.Article

Interleukin-3, interleukin-6, granulocyte-macrophage colony-stimulating factor and erythropoietin cord blood levels of preterm and term neonatesMEISTER, B; HEROLD, M; MAYR, A et al.European journal of pediatrics. 1993, Vol 152, Num 7, pp 569-573, issn 0340-6199Article

Nouvelles approches thérapeutiquesLyon Méditerranée médical. Médecine du sud-est. 1990, Vol 26, Num 5-6, pp 126-127, issn 0766-5466Conference Paper

Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapiesLI, Betty; SIMMONS, Andrew; DU, Thomas et al.Clinical immunology (Orlando, Fla. Print). 2009, Vol 133, Num 2, pp 184-197, issn 1521-6616, 14 p.Article

Contribution of dectin-1 and granulocyte macrophage-colony stimulating factor (GM-CSF) to immunomodulating actions of β-glucanHARADA, Toshie; OHNO, Naohito.International immunopharmacology. 2008, Vol 8, Num 4, pp 556-566, issn 1567-5769, 11 p.Article

Contribution of GM-CSF on the enhancement of the T cell-stimulating activity of macrophagesMAKINO, Masahiko; MAEDA, Yumi; FUKUTOMI, Yasuo et al.Microbes and infection. 2007, Vol 9, Num 1, pp 70-77, issn 1286-4579, 8 p.Article

Granulocyte-macrophage-colony-stimulating factor : a review from preclinical development to clinical applicationNEMUNAITIS, J.Transfusion (Philadelphia, PA). 1993, Vol 33, Num 1, pp 70-83, issn 0041-1132Article

GM-CSF treatment treatment of myelodysplastic syndromes : personal experience and preliminary results of a randomised international studyCOIFFIER, B; BASTION, Y; FELMAN, P et al.Pathologie et biologie. 1991, Vol 39, Num 9, pp 957-958, issn 0369-8114Article

Intérêt et place des facteurs de croissance hématopoïétique dans les agranulocytoses médicamenteuses : Facteurs de CroissanceANDRES, Emmanuel; MECILI, Mustapha; FEDERICI, Laure et al.MT. Médecine thérapeutique. 2009, Vol 15, Num 4, pp 267-272, issn 1264-6520, 6 p.Article

Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivityWAI MAN LIU; POWLES, Thomas; SHAMASH, Jonathan et al.Oncogene (Basingstoke). 2004, Vol 23, Num 4, pp 981-990, issn 0950-9232, 10 p.Article

Clinical pharmacokinetic studies of a human haemopoietic growth factor, GM-CSFHOVGAARD, D; MORTENSEN, B. T; SCHIFTER, S et al.European journal of clinical investigation. 1992, Vol 22, Num 1, pp 45-49, issn 0014-2972Article

Modulation of neutrophil and monocyte function by recombinant human granulocyte macrophage colony-stimulating factor in patients with lymphomaKHARAZMI, A; NIELSEN, H; HOVGAARD, D et al.European journal of clinical investigation. 1991, Vol 21, Num 2, pp 219-224, issn 0014-2972Article

The granulocyte/macrophage-colony stimulating factor (GM-CSF) : basic science and clinical applicationBURDACH, S.Klinische Pädiatrie. 1991, Vol 203, Num 4, pp 302-310, issn 0300-8630Article